Improved tools for monitoring primitive human blood development

STEMCELL Technologies is a rapidly growing Vancouver-based Canadian biotech company with more than 500 employees and annual sales of more than $80M worldwide primarily serving the burgeoning stem cell field. Blood stem cells were one of the first type of stem cell to be identified and have been used clinically for many transplantation applications for […]

Read More
Assistive Robotics Teleoperation and Autonomy Software Integration

This project aims to enhance Independence Robotics’ assistive robotic system by making it more powerful, modular, and reliable. We will upgrade the system’s hardware by transitioning from an Arduino Mega to an ESP32 microcontroller and integrating CAN bus communication for better sensor and actuator support. On the software side, we will develop real-time teleoperation controls […]

Read More
L2M_Business Strategy for CELLECT’s Research and Commercialization

Despite advancements in women’s health diagnostics, cervical cancer screening rates remain critically low due to the invasive nature of traditional collection methods like Pap smears and self-swabs. CELLECT is pioneering a non-invasive, nanotechnology-enabled collection device—the CELLECTPad—that passively captures high-quality cervical and epithelial cells during menstruation. By removing the discomfort and accessibility barriers of existing methods, […]

Read More
L2M – Strategic Development of ADAMTS13 as Novel Thrombolytic for Ischemic Stroke

We are developing a new treatment for ischemic stroke using a modified version of a natural anticoagulant called ADAMTS13. Existing stroke therapies are limited by a short treatment window and can carry serious risks. This new approach aims to safely extend the time patients can receive treatment, increasing access, especially for those in rural or […]

Read More
L2M_Launch_NanopHast_BSI_Project_Proposal

NanopHast is developing cutting-edge solid-state pH sensors designed to replace traditional glass pH electrodes. Our sensors offers miniaturized pH measurement, opening up novel possibilities in drug discovery and development. NanopHast has longer shelf life, lower manufacturing costs and a maintenance free design for users. Our goal is to redefine pH measurement standards and help drive […]

Read More
L2M- ZAP-010 – A natural, effective appetite suppressant

This project is focused on developing a novel, plant-based appetite suppressant called ZAP-010. Originally synthesized for agricultural use, ZAP-010 is a phytohormone that we have shown to reduce food intake and promote sustained weight loss in rodent models. Over 60% of Canadian adults are classified as overweight or obese and current treatment options, such as […]

Read More
L2M Launch- Vrit; A handheld bioprinting platform for treating severe skin wounds.

This project supports the commercialization of INSITE (In Situ Tissue Engineering Bioprinting System), a handheld bioprinting platform developed in the Guenther Lab at the University of Toronto. INSITE enables point-of-care delivery of personalized bioinks directly into skin wounds, offering a novel, autograft-free alternative for treating full-thickness burns and chronic wounds. Current gold-standard treatments rely on […]

Read More
L2M – The design and fabrication of inert meso- and micro-porous PEEK membranes

This project aims to help bring a new type of filtration membrane—made from a strong and reusable material called PEEK—to the market, specifically for use in making biopharmaceutical drugs. The main goal is to understand the current market, talk to companies and other key stakeholders to identify their specific needs, and develop a clear plan […]

Read More
L2M: Business Strategy for ECM-Plate—A Next-Generation 3D Tissue Model for Lung Fibrosis

This proposal focuses on developing a detailed commercialization strategy for a next-generation 3D tissue culture technology aimed at addressing key challenges in lung disease research. While advanced 3D culture methods can more accurately represent human physiology than traditional approaches, many of these systems remain expensive, complicated, or heavily reliant on specialized infrastructure. By contrast, our […]

Read More